Today: 9 June 2026
Youxin Technology Stock Jumps After $10.8 Million TikTok Partner Deal: What Is Behind the Move
28 April 2026
2 mins read

Youxin Technology Stock Jumps After $10.8 Million TikTok Partner Deal: What Is Behind the Move

Guangzhou, China, April 28, 2026, 06:01 (CST)

  • Youxin is set to acquire an 18% stake in YATOP, a partner specializing in TikTok advertising and commerce, through a share swap valued at $10.8 million.
  • Shares on the Nasdaq finished Monday at $2.32, a jump of 149.62%. After-hours, the stock slipped back.
  • Youxin would be venturing even deeper into cross-border social commerce with this deal, moving past its retail software roots—and stepping into territory known for high execution risk.

Youxin Technology Ltd saw its Nasdaq shares surge over 100% Monday, fueled by news that the Chinese retail software firm will acquire an 18% interest in YATOP Group Limited—a TikTok ecosystem partner—in a $10.8 million all-share deal. The agreement, finalized April 21, appeared in a Form 6-K filing with the U.S. Securities and Exchange Commission on April 27.

Youxin’s push comes as the company looks to boost its software business by layering on a quicker-growth commerce and advertising stream. Shares finished at $2.32, marking a 149.62% jump. The stock had swung between $1.28 and $2.57 during the session, before slipping to $1.90 in after-hours trading, StockAnalysis data show.

YATOP, headquartered in Hong Kong, launched operations in 2024. According to Youxin, the business posted unaudited revenue of $6.5 million for 2025 along with $2 million in net profit. For 2026, Youxin is forecasting revenue topping $10 million.

The target specializes in influencer marketing, short-form video, livestreaming ops, paid media, and e-commerce support. According to the company, it carries TikTok Shop Partner and Creator Agency Partner badges, along with other TikTok-linked credentials. GMV—gross merchandise value—refers to the total worth of items moved through the platform, before any deductions or refunds.

Chief Executive Shaozhang Lin described the deal as a “vital strategic step” for Youxin’s digital commerce ecosystem. The company added that it intends to co-develop software offerings with additional partners to help YATOP grow. GlobeNewswire

The filing puts the expected closing for the deal at around May 2026. Youxin pegged YATOP’s equity value at roughly $60.8 million, citing a third-party valuation for the purchase price.

Youxin’s statement follows its filing of audited financials for Celnet Technology Co., Ltd. just a week ago. The company picked up a 51% stake in Celnet back in October 2025. Celnet, which operates as a Salesforce.com partner in China, logged fiscal 2025 revenue at $2.8 million, with net income coming in at $0.3 million.

Youxin remains a small player. Over the past twelve months, StockAnalysis reports revenue of $539,474 against a net loss of $9.65 million. Following Monday’s rally, the company’s market cap stands at roughly $30.22 million.

Competition remains lively. Baozun Inc. positions itself as a brand e-commerce and digital commerce provider in China, while Weimob Inc. offers merchants cloud-based marketing and commerce software, plus growth services. In contrast, Youxin’s YATOP approach is more focused: it taps into TikTok—using its traffic, creators, and live commerce—rather than emphasizing traditional store operations.

There’s a chance the stock’s been bid up faster than the deal justifies. YATOP’s 2025 numbers haven’t been audited, the purchase only gets a minority position, and Youxin is paying with its own shares—not cash. Should TikTok commerce lose momentum, or if Youxin fails to convert YATOP’s agency business into recurring software sales, justifying the strategic upside could get tricky.

Stock Market Today

  • NOV Stock Up 32% in Six Months: Key Factors and Investor Outlook
    June 9, 2026, 10:21 AM EDT. NOV Inc. shares have surged 31.5% over six months, outpacing the Mechanical and Equipment Oil and Gas sub-industry and broader energy sector. The company benefits from strong offshore equipment demand, driven by subsea flexible pipe growth and offshore projects through 2028. NOV's focus on automation and cost reduction, including headcount and facility cuts, supports operational efficiency. Management anticipates a multi-year upcycle in capital equipment spending due to energy security and renewed offshore investment, bolstering demand. With a solid backlog and positive 2026 earnings outlook, NOV's positioning suggests potential for continued gains, raising questions for investors on whether to hold or sell amid market shifts.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Tesla Stock Price Today: TSLA Rises After Musk’s $115 Billion Share Filing — What Comes Next
Previous Story

Tesla Stock Price Today: TSLA Rises After Musk’s $115 Billion Share Filing — What Comes Next

US Stock Market Today: S&P 500, Nasdaq Hit Records as After-Hours Trading Edges Higher
Next Story

US Stock Market Today: S&P 500, Nasdaq Hit Records as After-Hours Trading Edges Higher

Go toTop